Fournier gangrene natural history, complications and prognosis

Jump to navigation Jump to search

Fournier gangrene Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fournier gangrene from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fournier gangrene natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fournier gangrene natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Fournier gangrene natural history, complications and prognosis

on Fournier gangrene natural history, complications and prognosis

Fournier gangrene natural history, complications and prognosis in the news

Blogs onFournier gangrene natural history, complications and prognosis

Directions to Hospitals Treating Fournier gangrene

Risk calculators and risk factors for Fournier gangrene natural history, complications and prognosis

Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]

Overview

If left untreated, the acute inflammatory changes spread quickly, accompanied by high fever and extreme weakness.[1][2] The overlying skin becomes smooth, tense and shiny and diffuse erythema without distinct borders are seen. During the first 1 or 2 days, the lesions develop with progressive color changes from red to purple to blue and then become gangrenous, first turning black, then greenish yellow. If the patient has survived, a line of demarcation between viable and necrotic tissue would become sharply defined from days 7 to 10. Sloughing of necrotic skin would reveal the underlying pus and extensive liquefactive necrosis of subcutaneous tissues, which will be significantly more extensive than would be suspected with the overlying area of necrotic skin. Metastatic abscesses and pulmonary distress may develop as well. Common complications of Fournier gangrene include:[3][4] Renal failure, acute respiratory distress syndrome, heart failure, cardiac arrhythmias, septic metastasis, urinary tract infection, stroke, acute thromboembolic disease of lower extremities, wound infection, prolonged ileus (7 days), and eventration or evisceration. Depending on the underlying comorbidities, the prognosis of Fournier gangrene varies. Some of the prognostic factors include: Presence of severe sepsis and whether the affected area calculation/extension of the necrosis is ≥5% of the body surface area.

Natural History, Complications, and Prognosis

Natural history

If left untreated, the acute inflammatory changes spread quickly, accompanied by high fever and extreme weakness.[1][2] The overlying skin becomes smooth, tense and shiny and diffuse erythema without distinct borders are seen.

During the first 1 or 2 days, the lesions develop with progressive color changes from red to purple to blue and then become gangrenous, first turning black, then greenish yellow. If the patient has survived, a line of demarcation between viable and necrotic tissue would become sharply defined from days 7 to 10.

Sloughing of necrotic skin would reveal the underlying pus and extensive liquefactive necrosis of subcutaneous tissues, which will be significantly more extensive than would be suspected with the overlying area of necrotic skin. Metastatic abscesses and pulmonary distress may develop as well.


The most common foci of Fournier gangrene include:[5][6]

Anorectal Genitourinary Dermatology Gynaecological

Neonates and Children

  • Trauma[6]
  • Burns
  • Insect bites
  • Circumcision

Complications

Common complications of Fournier gangrene include:[3][4]

Systemic complications

Surgical complications

  • Wound infection
  • Stoma-related complications
  • Prolonged ileus (7 days)
  • Eventration or evisceration

Long term complications

  • Pain (50% of patients)
  • Impaired sexual function (due to penile deviation/torsion, loss of sensitivity of the penile skin or pain during erection)
  • Stool incontinence
  • Extensive scarring

Prognosis

Depending on the underlying comorbidities, the prognosis of Fournier gangrene varies. Some of the prognostic factors include:

  • Severe sepsis
  • If the affected area calculation/extension of the necrosis is:
  • <3% of the body surface area, death is rare
  • ≥5% of the body surface area, the prognosis is worse

References

  1. 1.0 1.1 Morgan MS (2010). "Diagnosis and management of necrotising fasciitis: a multiparametric approach". J Hosp Infect. 75 (4): 249–57. doi:10.1016/j.jhin.2010.01.028. PMID 20542593.
  2. 2.0 2.1 Ecker KW, Derouet H, Omlor G, Mast GJ (1993). "[Fournier's gangrene]". Chirurg. 64 (1): 58–62. PMID 8436051.
  3. 3.0 3.1 Akcan A, Sözüer E, Akyildiz H, Yilmaz N, Küçük C, Ok E (2009). "Necessity of preventive colostomy for Fournier's gangrene of the anorectal region". Ulus Travma Acil Cerrahi Derg. 15 (4): 342–6. PMID 19669962.
  4. 4.0 4.1 Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I; et al. (2006). "Fournier's gangrene and its emergency management". Postgrad Med J. 82 (970): 516–9. doi:10.1136/pgmj.2005.042069. PMC 2585703. PMID 16891442.
  5. Eke N (2000). "Fournier's gangrene: a review of 1726 cases". Br J Surg. 87 (6): 718–28. doi:10.1046/j.1365-2168.2000.01497.x. PMID 10848848.
  6. 6.0 6.1 Amendola MA, Casillas J, Joseph R, Antun R, Galindez O (1994). "Fournier's gangrene: CT findings". Abdom Imaging. 19 (5): 471–4. PMID 7950832.